Impact of Psychiatric Disorders and Psychotropic Medications on Retention and Deployment

2013 ◽  
pp. 283-288
Author(s):  
David S. Shearer ◽  
Colette M. Candy
Keyword(s):  
Psychiatric Disorders ◽  
Psychotropic Medications

scholarly journals Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia

2021 ◽  
Author(s):  
Abdulkarim M. Meraya ◽  
Otilia J F Banji ◽  
Moteb A Khobrani ◽  
Abdulaziz Alhossan
Keyword(s):  
Saudi Arabia ◽  
Psychiatric Disorders ◽  
Psychotropic Medications

Sleep-Related Movement Disorders

2020 ◽  
pp. 193-214
Author(s):  
Ravi Gupta
Keyword(s):  
Movement Disorder ◽  
Psychiatric Disorders ◽  
Iron Metabolism ◽  
Restless Legs Syndrome ◽  
Movement Disorders ◽  
Genetic Factors ◽  
Psychotropic Medications ◽  
Predisposing Factors ◽  
Treatable Condition

Sleep-related movement disorders include disorders that manifest as simple and mostly stereotyped movements occurring at sleep–wake interface or during sleep. Restless legs syndrome (RLS), the most common sleep-related movement disorder. RLS is a treatable condition that psychiatrists must be familiar with due to its common comorbidity with a broad range of psychiatric disorders. In addition, commonly used psychotropic medications are known to induce or worsen RLS symptoms in predisposed individuals, and these symptoms may be mistaken for akathisia or sleep-initiation insomnia and lead to mismanagement. This chapter discusses, among other RLS-related topics, the diagnosis, epidemiology, predisposing factors, genetic factors, and the role of iron metabolism.

Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism

2004 ◽  
Vol 65 (12) ◽  
pp. 1607-1618 ◽  
Author(s):  
Madhusmita Misra ◽  
George I. Papakostas ◽  
Anne Klibanski
Keyword(s):  
Psychiatric Disorders ◽  
Bone Metabolism ◽  
Psychotropic Medications

Psychotropic Medications and Sleep

2020 ◽  
pp. 482-496
Author(s):  
William C. Jangro ◽  
Daniel A. Neff
Keyword(s):  
Psychiatric Disorders ◽  
Psychotropic Medications ◽  
Mood Stabilizers ◽  
Sleep Homeostasis ◽  
Psychiatric Population ◽  
Pharmacologic Agents

Psychiatric disorders, apart from impairing functioning during waking hours, also exert profound effects on sleep. The interventions used in treating these disorders can exert equally strong influences on sleep homeostasis. Pharmacologic agents that treat psychiatric disorders give rise to a broad range of effects on sleep, both beneficial and deleterious. This chapter reviews the available data on how sleep is affected by medications commonly used for the treatment of psychiatric disorders. While the focus will be on antidepressants, antiepileptic mood stabilizers, and antipsychotics, as these are the best studied medication classes in the psychiatric population, hypnotics and stimulants are also addressed. The authors focus, where available, on studies conducted in psychiatric populations.

The Process of Deprescribing

2019 ◽  
pp. 119-136
Author(s):  
Swapnil Gupta ◽  
Rebecca Miller ◽  
John D. Cahill
Keyword(s):  
Decision Making ◽  
Psychiatric Disorders ◽  
General Medicine ◽  
Psychotropic Medications ◽  
Withdrawal Symptoms ◽  
Decision Making Process ◽  
Close Monitoring ◽  
Cultural Meaning ◽  
Specific Context ◽  
Medication Changes

Deprescribing of psychotropic medications introduces additional complexities related to the specific context of psychiatric disorders and their cultural meaning. This chapter expands on the process of deprescribing as it relates specifically to psychiatry, taking the five essential steps of deprescribing in general medicine and elaborating on them for use in psychiatry. These include a detailed decision-making process, psychoeducation of both the patient and friends or family, and close monitoring and adaptation during medication reduction. Given the current absence of guidelines in this area, documentation is a key element of the process and is discussed in this chapter. Included are suggested templates to support accurate documentation, including the decision-making process, the patient’s response to medication changes, medication lists with their indications, and the appearance and management of withdrawal symptoms and/or relapse.

scholarly journals Zinc finger proteins in psychiatric disorders and response to psychotropic medications

2019 ◽  
Vol 29 (5) ◽  
pp. 132-141 ◽  
Author(s):  
Alessio Squassina ◽  
Anna Meloni ◽  
Caterina Chillotti ◽  
Claudia Pisanu
Keyword(s):  
Psychiatric Disorders ◽  
Zinc Finger ◽  
Zinc Finger Proteins ◽  
Psychotropic Medications

scholarly journals Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications

2020 ◽  
Vol 45 (13) ◽  
pp. 2229-2238
Author(s):  
Alessio Squassina ◽  
Mirko Manchia ◽  
Claudia Pisanu ◽  
Raffaella Ardau ◽  
Carlo Arzedi ◽  
...  
Keyword(s):  
Psychiatric Disorders ◽  
Psychotropic Medications ◽  
Telomere Attrition
Sign in / Sign up

Export Citation Format

Share Document